8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (Aug 6, 2012)

Filed August 6, 2012For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. (ALNY) filed a Form 8-K on August 6, 2012, to announce its financial results for the second quarter ended June 30, 2012. The primary purpose of this filing is to furnish the accompanying press release detailing these results. Investors should refer to the press release, filed as Exhibit 99.1, for specific financial performance and operational updates. This report serves as a notification of the earnings announcement and does not contain extensive new disclosures beyond the financial results themselves. The company has provided information regarding its operational and financial condition as of the reporting date, with the press release being the key document for understanding the quarter's performance and any forward-looking statements or strategic updates.

Key Highlights

  • 1Alnylam Pharmaceuticals (ALNY) filed an 8-K on August 6, 2012, reporting Q2 2012 financial results.
  • 2The filing includes a press release (Exhibit 99.1) detailing the financial and operational performance for the quarter ended June 30, 2012.
  • 3This report is primarily for informational purposes regarding the earnings announcement.
  • 4The information furnished via the press release is not considered 'filed' for Section 18 of the Exchange Act, nor incorporated by reference into other filings unless specifically stated.
  • 5Michael P. Mason, Vice President, Finance and Treasurer, signed the report on behalf of Alnylam.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and provide Alnylam Pharmaceuticals' financial results for the second quarter ended June 30, 2012, through an accompanying press release.

The detailed financial results are contained within the press release dated August 6, 2012, which is furnished as Exhibit 99.1 to this Form 8-K filing.

No, the information contained in the press release (Exhibit 99.1) furnished with this Form 8-K is not considered 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, unless specifically incorporated by reference into another filing.